CN105263525A - 抗微生物剂的组合物和制剂、它们的方法以及用于治疗微生物感染的方法 - Google Patents

抗微生物剂的组合物和制剂、它们的方法以及用于治疗微生物感染的方法 Download PDF

Info

Publication number
CN105263525A
CN105263525A CN201480030144.XA CN201480030144A CN105263525A CN 105263525 A CN105263525 A CN 105263525A CN 201480030144 A CN201480030144 A CN 201480030144A CN 105263525 A CN105263525 A CN 105263525A
Authority
CN
China
Prior art keywords
oil
combination
acid
present disclosure
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201480030144.XA
Other languages
English (en)
Chinese (zh)
Inventor
S·普拉萨德
S·高希
S·R·沙赖
N·哈因
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Viom Therapy Co Ltd
Original Assignee
Vyome Biosciences Pvt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vyome Biosciences Pvt Ltd filed Critical Vyome Biosciences Pvt Ltd
Publication of CN105263525A publication Critical patent/CN105263525A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241—Containing particulates characterized by their shape and/or structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/342—Alcohols having more than seven atoms in an unbroken chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/58—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/06—Preparations for styling the hair, e.g. by temporary shaping or colouring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/12—Preparations containing hair conditioners
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00—Manicure or pedicure preparations
    • A61Q3/02—Nail coatings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dispersion Chemistry (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
CN201480030144.XA 2013-04-12 2014-04-12 抗微生物剂的组合物和制剂、它们的方法以及用于治疗微生物感染的方法 Pending CN105263525A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN1103/DEL/2013 2013-04-12
IN1103DE2013 2013-04-12
PCT/IB2014/060675 WO2014167554A2 (en) 2013-04-12 2014-04-12 Composition and formulation of antimicrobial agents, processes thereof and methods for treating microbial infections

Publications (1)

Publication Number Publication Date
CN105263525A true CN105263525A (zh) 2016-01-20

Family

ID=50685993

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201480030144.XA Pending CN105263525A (zh) 2013-04-12 2014-04-12 抗微生物剂的组合物和制剂、它们的方法以及用于治疗微生物感染的方法

Country Status (9)

Country Link
US (1) US20160058775A1 (https=)
EP (1) EP2983714A2 (https=)
JP (2) JP6589086B2 (https=)
KR (1) KR101862448B1 (https=)
CN (1) CN105263525A (https=)
AU (1) AU2014252157B2 (https=)
EA (1) EA201591954A1 (https=)
HK (1) HK1220624A1 (https=)
WO (1) WO2014167554A2 (https=)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105902539A (zh) * 2016-03-31 2016-08-31 宝丽制药股份有限公司 抗三毛滴虫剂
CN106178024A (zh) * 2016-07-06 2016-12-07 安徽智博新材料科技有限公司 一种医用器具的长效消毒方法
CN106377757A (zh) * 2016-03-04 2017-02-08 广州英赛特生物技术有限公司 含氧碳氢衍生物作为多粘菌素的协同增效剂的应用
CN109689034A (zh) * 2016-06-13 2019-04-26 维奥梅治疗有限公司 协同抗真菌组合物及其方法
CN112205431A (zh) * 2020-09-14 2021-01-12 株洲千金药业股份有限公司 一种抑菌组合物和抑菌型婴幼儿衣物洗液及其制备方法
CN114072125A (zh) * 2019-07-09 2022-02-18 联合利华知识产权控股有限公司 包含抗头皮屑剂的毛发护理组合物

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110075310A (zh) * 2011-12-20 2019-08-02 维奥姆治疗有限公司 用于治疗真菌感染的局部油组合物
ES2784307T3 (es) * 2014-01-29 2020-09-24 Vyome Therapeutics Ltd Besifloxacina para el tratamiento del acné resistente
US10772343B2 (en) 2014-11-19 2020-09-15 Kansas State University Research Foundation Chemical mitigants in animal feed and feed ingredients
WO2016118644A1 (en) * 2015-01-20 2016-07-28 Plurogen Therapeutics, Llc Compositions and methods of treating microbes
US11684567B2 (en) 2015-08-05 2023-06-27 Cmpd Licensing, Llc Compositions and methods for treating an infection
US11446236B2 (en) 2015-08-05 2022-09-20 Cmpd Licensing, Llc Topical antimicrobial compositions and methods of formulating the same
US10898455B2 (en) 2016-01-07 2021-01-26 Cmpd Licensing, Llc Urea cream formulations
US11690815B2 (en) 2015-08-05 2023-07-04 Cmpd Licensing Llc Hyperkeratotic skin condition treatments and compositions
US11793783B2 (en) 2015-08-05 2023-10-24 Cmpd Licensing, Llc Compositions and methods for treating an infection
US20170173063A1 (en) * 2015-12-18 2017-06-22 Cmpd Licensing, Llc Compositions and Methods for Treating an Infection
WO2017216722A2 (en) * 2016-06-13 2017-12-21 Vyome Biosciences Pvt. Ltd. Synergistic antifungal compositions and methods thereof
GB201611365D0 (en) * 2016-06-30 2016-08-17 Devenish Nutrition Ltd A composition for use in treating rotavirus infection
WO2018134776A1 (en) * 2017-01-19 2018-07-26 Dr. Reddy’S Laboratories Limited Preservative free shampoo compositions
EA201992520A1 (ru) * 2017-07-12 2020-06-25 Юнилевер Н.В. Масло, улучшающее композицию для кожи
TR201714882A2 (tr) * 2017-10-03 2019-04-22 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Luli̇konazolün topi̇kal farmasöti̇k kompozi̇syonlari
US20210393520A1 (en) * 2018-02-12 2021-12-23 Vyome Therapeutics Limited Treatment of gram-negative folliculitis or an inflammation thereof with besifloxacin
KR101961366B1 (ko) * 2018-06-25 2019-03-25 (주) 아이나노 금 나노 입자가 분산 함유되어 있는 항균제 혹은 소취제 조성물, 및 이를 함유한 금나노 함유 제품
WO2020028319A1 (en) * 2018-07-30 2020-02-06 Sinica, Academia Therapeutic nanoparticles by coacervate complexation and their use for treating bacteria
US20220175827A1 (en) * 2019-04-05 2022-06-09 Northeastern University Biosynthesis of Selenium Nanoparticles Having Antimicrobial Activity
KR102241761B1 (ko) * 2019-08-07 2021-04-16 고려대학교 산학협력단 상온에서 속효성 살균 효과를 갖는 조성물
CN114450010A (zh) * 2019-10-11 2022-05-06 皮埃蒙特动物健康公司 耳用制剂、方法和装置
CN111000744B (zh) * 2020-01-07 2021-10-15 拉芳家化股份有限公司 一种含协同增效去屑组合的洗发香波
CN111286274A (zh) * 2020-03-06 2020-06-16 南雄市双溪丽盈化工涂料有限公司 高闪高透超丰满哑光清面漆
CN115551470A (zh) * 2020-04-23 2022-12-30 奥麒英国生物灭杀剂有限公司 含有亚烷基二醇酯的协同防腐剂/个人护理组合物
KR102197910B1 (ko) * 2020-08-06 2021-01-05 주식회사 씨엘바이오 피톤치드 함유 살균 및 살바이러스 조성물
CN112089684A (zh) * 2020-10-30 2020-12-18 华东医药（西安）博华制药有限公司 左奥硝唑/奥硝唑水包油乳温敏凝胶栓剂及其制备方法
CN112263499B (zh) * 2020-11-27 2023-05-23 佛山市南海东方澳龙制药有限公司 一种具有抗菌功能的动物香波及制备方法
BR112023012330A2 (pt) * 2020-12-21 2023-11-14 Oreal Usos cosméticos e processos cosméticos
FR3124077B1 (fr) * 2021-06-22 2025-05-02 Univ Nanyang Tech Utilisation d ’ un acide gras à cha î ne courte comme agent antipelliculaire
WO2022197627A1 (en) * 2021-03-15 2022-09-22 Drugarray, Inc. Combination therapy for treating covid-19
WO2022197626A1 (en) * 2021-03-15 2022-09-22 Drugarray, Inc. Combination therapy for treating covid-19
WO2022197625A1 (en) * 2021-03-15 2022-09-22 Drugarray, Inc. Combination therapy for treating covid-19
WO2022258404A1 (en) 2021-06-09 2022-12-15 Unilever Ip Holdings B.V. Topical composition for restoring microbial diversity of scalp
WO2025078569A1 (en) * 2023-10-13 2025-04-17 Arch Uk Biocides Ltd Antimicrobial composition
WO2026039712A1 (en) * 2024-08-16 2026-02-19 Arch Uk Biocides Limited Antimicrobial composition comprising an alkylene glycol ester producing a biocidal or biostatic effect on microorganisms on the skin

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4406884A (en) * 1981-06-23 1983-09-27 The Procter & Gamble Company Topical antimicrobial composition
US5698219A (en) * 1994-08-08 1997-12-16 Laboratorios Cusi, S.A. Nanoemulsion of the oil water type, useful as an ophthalmic vehicle and process for the preparation thereof
CN1531430A (zh) * 2001-03-30 2004-09-22 ŵ�����˹ɷ����޹�˾ 含有抗真菌剂的局部用组合物
US7198794B1 (en) * 2002-02-22 2007-04-03 Lorri Riley Topical formulation for treating fingernails and toenails
US20110195944A1 (en) * 2008-10-08 2011-08-11 Polichem Sa Modified release emulsions for application to skin or vaginal mucosa
WO2012017349A2 (en) * 2010-08-02 2012-02-09 Ranbaxy Laboratories Limited An improved topical pharmaceutical composition comprising nanonized silver sulfadiazine
US20120087959A1 (en) * 2009-06-19 2012-04-12 Sun Pharma Advanced Research Company Limited Nanodispersion of a drug and process for its preparation
US20130011452A1 (en) * 2009-02-25 2013-01-10 Loupenok Leon Topical foam composition

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0116439A3 (en) 1983-02-02 1986-01-29 Suntory Limited Fatty acid containing hair tonic composition
DE3339236A1 (de) * 1983-10-28 1985-05-09 Bayer Ag Arzneimittelzubereitung
US5198209A (en) * 1992-02-11 1993-03-30 Amway Corporation Conditioning shampoo
ES2068762B1 (es) * 1993-07-21 1995-12-01 Lipotec Sa Un nuevo preparado farmaceutico para mejorar la biodisponibilidad de drogas de dificil absorcion y procedimiento para su obtencion.
SE9303744D0 (sv) * 1993-11-12 1993-11-12 Astra Ab Pharmaceutical emulsion
US5624666A (en) 1995-01-20 1997-04-29 The Procter & Gamble Company Anti-dandruff shampoos with particulate active agent and cationic polymer
CA2317106C (en) * 1997-12-31 2004-11-23 Choongwae Pharma Corporation Method and composition of an oral preparation of itraconazole
FR2774900B1 (fr) * 1998-02-13 2000-03-31 Ceca Sa Shampoings antipelliculaires transparents
FR2780889B1 (fr) * 1998-07-10 2001-08-31 Concept Utilisation d'un inhibiteur du cytochrome p450 eventuellement en association avec un antifongique pour le traitement des mycoses
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US6623765B1 (en) * 2000-08-01 2003-09-23 University Of Florida, Research Foundation, Incorporated Microemulsion and micelle systems for solubilizing drugs
US6500861B1 (en) * 2000-08-23 2002-12-31 Michael D. Wider Antimicrobial composition and methods of use in the treatment of disease
US6673373B2 (en) * 2001-02-01 2004-01-06 Carlsbad Technology Inc. Antifungal formulation and the methods for manufacturing and using the same
TW200407172A (en) 2002-10-17 2004-05-16 Unilever Nv Scalp treatment
US20040202636A1 (en) * 2003-04-11 2004-10-14 Kaczvinsky Joseph Robert Personal care composition containing an antidandruff component and a nonionic surfactant
EP2295036A2 (en) * 2004-12-10 2011-03-16 Talima Therapeutics, Inc. Liquid compositions and methods for treating conditions of the nail unit
JP2008532971A (ja) * 2005-03-08 2008-08-21 チバ ホールディング インコーポレーテッド 特定のホスホネートにより被覆された金属酸化物ナノ粒子
BRPI0713209A2 (pt) 2006-07-07 2012-03-20 Unilever N.V composição de condicionamento de cabelos e método de mitigar caspa
EP1923043A1 (en) 2006-11-16 2008-05-21 KPSS-Kao Professional Salon Services GmbH Anti-dandruff conditioner composition
JP2011518844A (ja) * 2008-04-25 2011-06-30 ナノバイオ コーポレーション 真菌、酵母および糸状菌感染症を治療するためのナノエマルション
US9480627B2 (en) * 2010-09-15 2016-11-01 Steven D. Jensen Long term bacteriostatic compounds and their use in restorative dental materials
BR112013033239A2 (pt) * 2011-06-22 2016-09-06 Vyome Biosciences pró-farmácos de conjugado baseado em atifungicos e antibacterianos

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4406884A (en) * 1981-06-23 1983-09-27 The Procter & Gamble Company Topical antimicrobial composition
US5698219A (en) * 1994-08-08 1997-12-16 Laboratorios Cusi, S.A. Nanoemulsion of the oil water type, useful as an ophthalmic vehicle and process for the preparation thereof
CN1531430A (zh) * 2001-03-30 2004-09-22 ŵ�����˹ɷ����޹�˾ 含有抗真菌剂的局部用组合物
US7198794B1 (en) * 2002-02-22 2007-04-03 Lorri Riley Topical formulation for treating fingernails and toenails
US20110195944A1 (en) * 2008-10-08 2011-08-11 Polichem Sa Modified release emulsions for application to skin or vaginal mucosa
US20130011452A1 (en) * 2009-02-25 2013-01-10 Loupenok Leon Topical foam composition
US20120087959A1 (en) * 2009-06-19 2012-04-12 Sun Pharma Advanced Research Company Limited Nanodispersion of a drug and process for its preparation
WO2012017349A2 (en) * 2010-08-02 2012-02-09 Ranbaxy Laboratories Limited An improved topical pharmaceutical composition comprising nanonized silver sulfadiazine

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106377757A (zh) * 2016-03-04 2017-02-08 广州英赛特生物技术有限公司 含氧碳氢衍生物作为多粘菌素的协同增效剂的应用
WO2017147958A1 (zh) * 2016-03-04 2017-09-08 广州英赛特生物技术有限公司 含氧碳氢衍生物作为多粘菌素的协同增效剂的应用
CN109512999A (zh) * 2016-03-04 2019-03-26 广州英赛特生物技术有限公司 含氧碳氢衍生物的脂肪醇作为多粘菌素的协同增效剂的应用
CN109512998A (zh) * 2016-03-04 2019-03-26 广州英赛特生物技术有限公司 含氧碳氢衍生物的酯化衍生物作为多粘菌素的协同增效剂的应用
CN105902539A (zh) * 2016-03-31 2016-08-31 宝丽制药股份有限公司 抗三毛滴虫剂
CN109689034A (zh) * 2016-06-13 2019-04-26 维奥梅治疗有限公司 协同抗真菌组合物及其方法
CN106178024A (zh) * 2016-07-06 2016-12-07 安徽智博新材料科技有限公司 一种医用器具的长效消毒方法
CN114072125A (zh) * 2019-07-09 2022-02-18 联合利华知识产权控股有限公司 包含抗头皮屑剂的毛发护理组合物
CN114072125B (zh) * 2019-07-09 2024-03-26 联合利华知识产权控股有限公司 包含抗头皮屑剂的毛发护理组合物
CN112205431A (zh) * 2020-09-14 2021-01-12 株洲千金药业股份有限公司 一种抑菌组合物和抑菌型婴幼儿衣物洗液及其制备方法

Also Published As

Publication number Publication date
JP6589086B2 (ja) 2019-10-16
HK1220624A1 (zh) 2017-05-12
KR101862448B1 (ko) 2018-05-29
JP2016516765A (ja) 2016-06-09
AU2014252157A1 (en) 2015-11-05
US20160058775A1 (en) 2016-03-03
KR20150138392A (ko) 2015-12-09
EA201591954A1 (ru) 2016-04-29
EP2983714A2 (en) 2016-02-17
AU2014252157B2 (en) 2017-05-11
WO2014167554A3 (en) 2014-12-24
WO2014167554A2 (en) 2014-10-16
JP2019031561A (ja) 2019-02-28

Similar Documents

Publication Publication Date Title
KR101862448B1 (ko) 항균제의 조성물과 제제, 그 공정, 및 세균 감염을 치료하는 방법
JP6653342B2 (ja) 真菌感染症の治療用の局所用オイル組成物
KR20190037229A (ko) 상승효과적 항진균 조성물 및 그의 방법
CN106163526B (zh) 抗性痤疮的治疗
KR100983802B1 (ko) 폴리히드록시알칸의 지방산 에스테르 및 피리미딘카르복시 유도체의 신규한 복합체
US8076484B2 (en) Modified green tea polyphenol formulations
JP2011529038A5 (https=)
US20170096381A1 (en) Use of vanillin derivatives as preserving agents, preserving process, compounds and composition
US20130267490A1 (en) Topical pharmaceutical composition comprising nanonized silver sulfadiazine and chlorhexidine gluconate
WO2018084112A1 (ja) アクネ菌株選択的抗菌剤
JP2006070025A (ja) 防腐防黴剤含有組成物
JP2009167139A (ja) 外用組成物
JP2021512145A (ja) 皮膚感染の予防または治療用組成物
WO2025222091A1 (en) Poly inflammatory kinase inhibitors and pharmaceutical compositions
HK40064465A (en) Treatments for resistant acne
WO2025222091A9 (en) Poly inflammatory kinase inhibitors and pharmaceutical compositions

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1220624

Country of ref document: HK

TA01 Transfer of patent application right
TA01 Transfer of patent application right

Effective date of registration: 20190220

Address after: India New Delhi

Applicant after: Viom Therapy Co., Ltd.

Address before: India New Delhi

Applicant before: VYOME BIOSCIENCES

RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20160120

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1220624

Country of ref document: HK